In this article, we are going to take a look at where Apogee Therapeutics, Inc. (NASDAQ:APGE) stands against the other small-cap stocks. The S&P 500 index has reached its all-time highs ...

On Monday (Feb. 17), the moon reaches what's known as apogee — its farthest point away from Earth. The moon's orbit is elliptical, or oval-shaped, meaning its distance from Earth changes ...

In a report released yesterday, Charlie CY Yang from Bank of America Securities maintained a Buy rating on Apogee Therapeutics (APGE – Research Report), with a price target of $80.00.

In a small sign of a possible improvement in the sluggish biotech initial public offering (IPO) market, Apogee Therapeutics has said it expects gross proceeds of $300 million from its Nasdaq ...

Vocalist/bassist Dave “Dixie” Collins has done time in heavyweights Buzzoven, Bongzilla, and Sourvein. Thus, Weedeater unsurprisingly brings more downtuned filth, this time in the NOLA sludge/doom ...